Trading Signals: SONN Stock Price Prediction and Forecast (Mon. Aug. 24, 2015 - Thu. Apr. 30, 2020)(Sonnet BioTherapeutics Holdings, Inc.)
| SONN latest price $121.7100 (2.88%) ($110.9900 - $126.7500) on Wed. Nov. 2, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.06% (three month average) | RSI | 51 | Latest Price | $121.7100(2.88%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SONN declines -0.5% a day on average for past five trading days. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support SONN advance at 0% a week (0% probability) IWN(17%) QQQ(17%) SDY(17%) SKYY(17%) TBT(17%) | Factors Impacting SONN price | SONN will decline at least -3.03% in a week (0% probabilities). VCSH(-27%) LQD(-20%) TLT(-19%) VCIT(-15%) CEMB(-15%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.03% (StdDev 6.06%) | Hourly BBV | 0 () | Intraday Trend | 4.3% | | | |
|
1 - 5 Day Possible Target | $112.75(-7.36%) | Resistance Level | $121.93 | 5 Day Moving Average | $119.76(1.63%) | 10 Day Moving Average | $120.55(0.96%) | 20 Day Moving Average | $121.93(-0.18%) | To recent high | -25.7% | To recent low | 21.2% | Market Cap | $1.12b | | | | Sonnet BioTherapeutics Holdings, Inc. engages in the development of biologic drugs with enhanced single or bispecific mechanisms. Its technology utilizes a fully human single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. The company was founded on April 1, 2020 and is headquartered in Princeton, New Jersey. |